Ivax gets Canadian Paxene approval

IVX received approval to market its Paxene paclitaxel in Canada to treat AIDS-related Kaposi's sarcoma in patients who fail liposomal anthracycline therapy. Pacliataxel is marketed in the U.S. and els...